This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TP Minds Digital
16:00 AEST | 07:00 BST
16:00 AEST | 07:00 BST

TP Minds Digital

Your digital hub for exclusive free content curated by the TP Minds team for our global audience.

The latest webinars, interviews and virtual roundtables analysing the current Transfer Pricing developments.

Webinar topics:

Year End Planning and IFRIC 23

10 June 2020

Covering insights on how COVID-19 impacts Transfer Pricing arrangements, how to assess the Transfer Pricing risks it presents and strategies to best navigate these risks during the year-end close.

Managing TP in the Short & Long Term

17 June 2020

Covering the key issues and concerns, we have hand-picked the most contentious issues multinationals are dealing with.

Can You Afford Not To Review Your Transfer Pricing Agreements In The COVID-19 Environment?

24 June 2020

Covering practical transfer pricing and legal insights in relation to related party agreements, including potential cash flow and tax implications when transfer pricing agreements are ignored.

Cross Border Financing Arrangements - How to Manage and Benefit in a World Impacted by COVID-19

1 July 2020

Insights and examples on how COVID-19 impacts transfer pricing financing arrangements and hear what influences companies’ decisions of how to structure financing arrangements in the current environment. The Australian Taxation Office (ATO) will discuss available COVID related concessions and likely ATO approach to compliance post COVID, specifically focusing on financing arrangements.


How Edwards Lifesciences is Taking a Strategic Approach to Transfer Pricing

Arthur Bichler (Edwards Lifesciences) and Jamie Eagan (Longview) dicussed the business conditions that led to the need for investment in technology, the challenges they've overcome, and their long-term vision for the role of technology in improving Operational Transfer Pricing analysis, reporting, adjustments and price setting for Edwards Lifesciences.